Feasibility and acceptability of personalised breast cancer screening (DECIDO study): protocol of a single-arm proof-of-concept trial
Data de publicació2020-12-23
Pons Rodríguez, Anna
Reñé Reñé, Mercè
Hernández Andreu, Marta
Galindo Ortego, Gisela
Llorens Gabandé, Montserrat
Balaguer Llaquet, Pau
MetadadesMostra el registre d'unitat complet
Introduction Personalised cancer screening aims to improve benefits, reduce harms and being more cost-effective than age-based screening. The objective of the DECIDO study is to assess the acceptability and feasibility of offering risk-based personalised breast cancer screening and its integration in regular clinical practice in a National Health System setting. Methods and analysis The study is designed as a single-arm proof-of-concept trial. The study sample will include 385 women aged 40-50 years resident in a primary care health area in Spain. The study intervention consists of (1) a baseline visit; (2) breast cancer risk estimation; (3) a second visit for risk communication and screening recommendations based on breast cancer risk and (4) a follow-up to obtain the study outcomes. A polygenic risk score (PRS) will be constructed as a composite likelihood ratio of 83 single nucleotide polymorphisms. The Breast Cancer Surveillance Consortium risk model, including age, race/ethnicity, family history of breast cancer, benign breast disease and breast density will be used to estimate a preliminary 5-year absolute risk of breast cancer. A Bayesian approach will be used to update this risk with the PRS value. The primary outcome measures will be attitude towards, intention to participate in and satisfaction with personalised breast cancer screening. Secondary outcomes will include the proportions of women who accept to participate and who complete the different phases of the study. The exact binomial and the Student's t-test will be used to obtain 95% CIs. Ethics and dissemination The study protocol was approved by the Drug Research Ethics Committee of the University Hospital Arnau de Vilanova. The trial will be conducted in compliance with this study protocol, the Declaration of Helsinki and Good Clinical Practice. The results will be published in peer-reviewed scientific journals and disseminated in scientific conferences and media. Trial registration number NCT03791008.
És part deBmj Open, 2020, vol. 10, num. 12, p. e044597
Projectes de recerca europeus
Els fitxers de llicència següents estan associats amb aquest element:
Aquest document està subjecte a una llicència Creative Commons.cc-by-nc (c) Pons Rodríguez, Anna et al., 2020
Mostrant elements relacionats per títol, autor i matèria.
Efficacy and tolerance of the topical application of potassium hydroxide (10% and 15%) in the treatment of molluscum contagiosum: Randomized clinical trial: Research protocol Marsal Mora, Josep Ramon; Cruz Esteve, María Inés; Teixidó Armengol, Conxita; Díez, Olga; Martínez, Mireia; Galindo Ortego, Gisela; Real, Jordi; Schoenenberger, Joan Antoni; Pera, Helena (BioMed Central, 2011)Background: Molluscum contagiosum is a non-severe pediatric viral infection. Because it is highly contagious and current treatments have negative aesthetic and psychological effects, we want to test an alternative treatment ...
Evaluation of a family intervention programme for the treatment of overweight and obese children (Nereu Programme): a randomized clinical trial study protocol Serra Payà, Noemí; Ensenyat Solé, Assumpta; Real, Jordi; Castro Viñuales, Ivan; Zapata Rojas, Amalia; Galindo Ortego, Gisela; Solé Mir, Eduard; Bosch Muñoz, Jordi; Mur, José María; Teixidó Armengol, Conxita (BioMed Central, 2013)Background: Obesity is mainly attributed to environmental factors. In developed countries, the time spent on physical activity tasks is decreasing, whereas sedentary behaviour patterns are increasing. The purpose of the ...
Blanch, Jordi; Sala i Serra, Maria; Román Expósito, Marta; Ederra, M.; Salas, Dolores; Zubizarreta, Raquel; Sánchez-Jacob, Mercedes; Rué i Monné, Montserrat; Castells, Xavier (Springer Verlag, 2013)Background There is little information on the individual risk of screen-detected cancer in women over successive participations. This study aimed to estimate the 10-year cumulative breast cancer detection risk ...